Sigma-Aldrich, Proligo, Thermo Electron, NIH, Clontech, GE Healthcare | GenomeWeb

Sigma-Aldrich to Acquire
Proligo; Shelves India Facility

Sigma-Aldrich plans to purchase DNA and RNA maker Proligo from Degussa, the company said this week.

Proligo, headquartered in Boulder, Colo., provides custom DNA, RNA, and raw materials for DNA and RNA synthesis. The company is one of four exclusive licensees to an RNAi patent application owned by MIT.

Last year, Proligo had approximately $40 million in sales. The 300-employee company has manufacturing sites in Boulder, France, Germany, Singapore, Japan, and Australia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.